
A former Lazard banker saw a business in the royalties other people were waiting to collect. Thirty years after founding Royalty Pharma, Pablo Legorreta is still rearranging the relationship between money and time.
A $3.3 billion cheque to a cystic fibrosis charity reveals the idea behind Royalty Pharma: turn tomorrow’s drug royalties into money that can do something now.